Clinical Trial Update: An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be Assessed [Phase 1]

View source ↗

Summary

This open-label Phase 1 study assessed the pharmacokinetics of digoxin when given with various doses of ezogabine/retigabine in healthy adults, and evaluated th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• DIGOXIN (Digoxin)
• Ezogabine/Retigabine (ezogabine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Phase 1 | Status: COMPLETED